SCHEMBL2362712

SCHEMBL2362712

O=C(Nc1ccc(Oc2ccc(Cl)cc2)cc1)[C@H]1C[C@@H](Cc2ccccc2)CN1C(=O)Cn1cncn1

nearest known ligand 0.85

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 9/20 0.85
CYP2C9 P11712 6/20 0.85
CYP2D6 P10635 6/20 0.85
CYP3A4 P08684 3/20 0.78
MAPT P10636 1/20 0.40
MC4R P32245 1/20 0.38
MC3R P41968 1/20 0.38
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38
FAAH O00519 3/20 0.37
CFTR P13569 2/20 0.37
UBE2M P61081 1/20 0.37
DCUN1D1 Q96GG9 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2362711 1.00 S1PR1 (0.85) S1PR1CYP2C9CYP2D6CYP3A4MAPT
SCHEMBL1372429 1.00 S1PR1 (0.85) S1PR1CYP2C9CYP2D6CYP3A4MAPT
SCHEMBL1373685 0.92 S1PR1 (1.00) S1PR1CYP2C9CYP2D6CYP3A4MC4R
SCHEMBL2170080 0.92 S1PR1 (1.00) S1PR1CYP2C9CYP2D6CYP3A4MC4R
SCHEMBL1373750 0.88 S1PR1 (0.83) S1PR1CYP2C9CYP2D6CYP3A4FAAH
SCHEMBL2186351 0.88 S1PR1 (0.83) S1PR1CYP2C9CYP2D6CYP3A4FAAH
SCHEMBL1374243 0.88 S1PR1 (1.00) S1PR1CYP2C9CYP2D6CYP3A4LMNA
SCHEMBL2171064 0.88 S1PR1 (1.00) S1PR1CYP2C9CYP2D6CYP3A4LMNA
SCHEMBL1374743 0.88 S1PR1 (1.00) S1PR1CYP2C9CYP2D6CYP3A4LMNA
SCHEMBL12044792 0.87 S1PR1 (0.77) S1PR1CYP2C9CYP2D6CYP3A4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2349252-A2 SYNERGISTIC COMBINATION OF SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS AND ANTIMICROTUBULE AGENTS Exelixis, Inc. (US) 2011-08-03 EP disclosed
WO-2010045601-A2 SYNERGISTIC EFFECTS BETWEEN SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS AND ANTIMICROTUBULE AGENTS EXELIXIS, INC. (US) 2010-04-22 WO disclosed